StonvexLoading…
StonvexStonvexStonvexCore line items from CEG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.54B | $22.66B | $16.97B | $11.27B |
Operating Income | $2.33B | $3.09B | $2.49B | $1.40B |
Net Income | $1.59B | $2.32B | $1.89B | $957.00M |
EPS (Diluted) | $4.49 | $7.40 | $6.02 | $3.05 |
Total Assets | $96.91B | $57.25B | $56.16B | $53.04B |
Total Liabilities | $63.09B | $42.40B | $41.47B | $39.23B |
Cash & Equivalents | $800.00M | $3.64B | $3.96B | $1.97B |
Free Cash Flow OCF − CapEx | $-850.00M | $1.29B | $1.47B | $11.00M |
Shares Outstanding | 362.00M | 312.00M | 312.00M | 312.00M |